M W Kline

Summary

Affiliation: Baylor College of Medicine
Country: USA

Publications

  1. ncbi Long-term follow-up of 414 HIV-infected Romanian children and adolescents receiving lopinavir/ritonavir-containing highly active antiretroviral therapy
    Mark W Kline
    Baylor College of Medicine International Pediatric AIDS Initiative, Texas Children s Hospital, Houston, Texas, USA
    Pediatrics 119:e1116-20. 2007
  2. ncbi Comprehensive pediatric human immunodeficiency virus care and treatment in Constanta, Romania: implementation of a program of highly active antiretroviral therapy in a resource-poor setting
    Mark W Kline
    Department of Pediatrics, Baylor College of Medicine and Texas Children s Hospital, Houston, TX 77030, USA
    Pediatr Infect Dis J 23:695-700. 2004
  3. ncbi Disparity between pediatricians' knowledge and practices regarding perinatal human immunodeficiency virus counseling and testing
    Mark W Kline
    Committee on Pediatric AIDS, American Academy of Pediatrics, Elk Grove Village, Illinois, USA
    Pediatrics 112:e367. 2003
  4. ncbi Combination therapy with saquinavir soft gelatin capsules in children with human immunodeficiency virus infection
    M W Kline
    Department of Pediatrics, Baylor College of Medicine and Texas Children s Hospital, Houston 77030, USA
    Pediatr Infect Dis J 20:666-71. 2001
  5. ncbi Pilot study of hydroxyurea in human immunodeficiency virus-infected children receiving didanosine and/or stavudine
    M W Kline
    Department of Pediatrics, Baylor College of Medicne, Texas Children s Hospital, Houston 77030, USA
    Pediatr Infect Dis J 19:1083-6. 2000
  6. ncbi Isolation of Lautropia mirabilis from oral cavities of human immunodeficiency virus-infected children
    S N Rossmann
    Baylor College of Medicine and Texas Children s Hospital, Houston 77030, USA
    J Clin Microbiol 36:1756-60. 1998
  7. ncbi Recombinant human gamma interferon in human immunodeficiency virus-infected children: safety, CD4(+)-lymphocyte count, viral load, and neutrophil function (AIDS Clinical Trials Group Protocol 211)
    W T Shearer
    Departments of Pediatrics and Microbiology and Immunology, Baylor College of Medicine, Texas Children s Hospital, Houston 77030, USA
    Clin Diagn Lab Immunol 6:311-5. 1999
  8. ncbi Transport of recombinant human CD4-immunoglobulin G across the human placenta: pharmacokinetics and safety in six mother-infant pairs in AIDS clinical trial group protocol 146
    W T Shearer
    Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA
    Clin Diagn Lab Immunol 2:281-5. 1995
  9. ncbi Dental caries in HIV-infected children: a longitudinal study
    M J Hicks
    Department of Pathology, Baylor College of Medicine, USA
    Pediatr Dent 22:359-64. 2000
  10. ncbi Oral manifestations of pediatric vertical HIV infection
    C A Kozinetz
    Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA
    AIDS Patient Care STDS 14:89-94. 2000

Collaborators

Detail Information

Publications32

  1. ncbi Long-term follow-up of 414 HIV-infected Romanian children and adolescents receiving lopinavir/ritonavir-containing highly active antiretroviral therapy
    Mark W Kline
    Baylor College of Medicine International Pediatric AIDS Initiative, Texas Children s Hospital, Houston, Texas, USA
    Pediatrics 119:e1116-20. 2007
    ....
  2. ncbi Comprehensive pediatric human immunodeficiency virus care and treatment in Constanta, Romania: implementation of a program of highly active antiretroviral therapy in a resource-poor setting
    Mark W Kline
    Department of Pediatrics, Baylor College of Medicine and Texas Children s Hospital, Houston, TX 77030, USA
    Pediatr Infect Dis J 23:695-700. 2004
    ..S. health care institution and the Romanian government, has established a comprehensive program of highly active antiretroviral therapy for children in Constanta, Romania...
  3. ncbi Disparity between pediatricians' knowledge and practices regarding perinatal human immunodeficiency virus counseling and testing
    Mark W Kline
    Committee on Pediatric AIDS, American Academy of Pediatrics, Elk Grove Village, Illinois, USA
    Pediatrics 112:e367. 2003
    ....
  4. ncbi Combination therapy with saquinavir soft gelatin capsules in children with human immunodeficiency virus infection
    M W Kline
    Department of Pediatrics, Baylor College of Medicine and Texas Children s Hospital, Houston 77030, USA
    Pediatr Infect Dis J 20:666-71. 2001
    ....
  5. ncbi Pilot study of hydroxyurea in human immunodeficiency virus-infected children receiving didanosine and/or stavudine
    M W Kline
    Department of Pediatrics, Baylor College of Medicne, Texas Children s Hospital, Houston 77030, USA
    Pediatr Infect Dis J 19:1083-6. 2000
    ..To evaluate the safety and antiviral and immunologic effects of hydroxyurea given with didanosine (ddI) and/or stavudine (d4T) to symptomatic HIV-infected children...
  6. ncbi Isolation of Lautropia mirabilis from oral cavities of human immunodeficiency virus-infected children
    S N Rossmann
    Baylor College of Medicine and Texas Children s Hospital, Houston 77030, USA
    J Clin Microbiol 36:1756-60. 1998
    ..mirabilis in immunological status, clinical status, or systemic medications. The role of HIV infection itself or concomitant factors in the establishment of L. mirabilis in the oral cavity remains to be elucidated...
  7. ncbi Recombinant human gamma interferon in human immunodeficiency virus-infected children: safety, CD4(+)-lymphocyte count, viral load, and neutrophil function (AIDS Clinical Trials Group Protocol 211)
    W T Shearer
    Departments of Pediatrics and Microbiology and Immunology, Baylor College of Medicine, Texas Children s Hospital, Houston 77030, USA
    Clin Diagn Lab Immunol 6:311-5. 1999
    ....
  8. ncbi Transport of recombinant human CD4-immunoglobulin G across the human placenta: pharmacokinetics and safety in six mother-infant pairs in AIDS clinical trial group protocol 146
    W T Shearer
    Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA
    Clin Diagn Lab Immunol 2:281-5. 1995
    ..In summary, these findings document that bifunctional immune molecules can be transported across the placenta, and this general approach may be used in the future to block vertical transmission of HIV type 1...
  9. ncbi Dental caries in HIV-infected children: a longitudinal study
    M J Hicks
    Department of Pathology, Baylor College of Medicine, USA
    Pediatr Dent 22:359-64. 2000
    ....
  10. ncbi Oral manifestations of pediatric vertical HIV infection
    C A Kozinetz
    Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA
    AIDS Patient Care STDS 14:89-94. 2000
    ..Oral manifestations are significant clinical outcomes in pediatric vertical HIV infection, particularly for children diagnosed previously with an oral manifestation...
  11. ncbi Citrobacter diversus and neonatal brain abscess
    M W Kline
    Myers Black Section of Pediatric Infectious Diseases, Baylor College of Medicine and Texas Children s Hospital, Houston 77030
    Pediatr Neurol 3:178-80. 1987
    ..A high prevalence of brain abscess mandates cranial computed tomography for any infant with C. diversus meningitis...
  12. ncbi No greater gift than hope
    Mark W Kline
    Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA
    Semin Pediatr Infect Dis 14:309-13. 2003
  13. ncbi Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection
    Walter T Hughes
    Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
    Clin Infect Dis 40:136-45. 2005
    ....
  14. ncbi Longitudinal study of the prevalence and prognostic implications of oral manifestations in romanian children infected with human immunodeficiency virus type 1
    Nicoleta Vaseliu
    Romanian-American Children's Center, Constanta, Romania
    Pediatr Infect Dis J 24:1067-71. 2005
    ..003) for those who had oral hairy leukoplakia. CONCLUSIONS: Oral manifestations occur commonly among HIV-infected Romanian children. Oral candidiasis and oral hairy leukoplakia were positive predictors of HIV disease progression...
  15. ncbi Influence of institutionalization on time to HIV disease progression in a cohort of Romanian children and teens
    Margaret Ferris
    Baylor College of Medicine, Department of Pediatrics, 6621 Fannin St, CCC1210, Houston, TX 77030, USA
    Pediatrics 120:e1476-80. 2007
    ..The purpose of this work was to investigate the effect of institutionalization on death and CD4 decline in a cohort of 325 HIV-infected Romanian children...
  16. ncbi Disseminated Acanthamoeba infection in a human immunodeficiency virus-infected infant
    Heidi Schwarzwald
    Department of Pediatrics, Baylor College of Medicine and Texas Children s Hospital, Houston, 77030, USA
    Pediatr Infect Dis J 22:197-9. 2003
    ..We present the first case of disseminated Acanthamoeba infection in an HIV-infected infant. The infant survived 2 years with treatment with several agents having anti-Acanthamoeba activity in vitro...
  17. ncbi False negative DNA polymerase chain reaction in an infant with subtype C human immunodeficiency virus 1 infection
    Nancy E Kline
    Section of Retrovirology, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX 77030, USA
    Pediatr Infect Dis J 21:885-6. 2002
    ..Clinicians should be aware of this particular limitation of HIV DNA PCR assays, because it is likely that an increasing proportion of the HIV-infected infants seen in US centers will be infected with non-subtype B HIV...
  18. ncbi Efavirenz liquid formulation in human immunodeficiency virus-infected children
    Stuart E Starr
    Division of Infectious and Immunologic Diseases, Abramson Research Center, The Children s Hospital of Philadelphia, PA 19104, USA
    Pediatr Infect Dis J 21:659-63. 2002
    ....
  19. ncbi Magnitude of IFN-gamma production in HIV-1-infected children is associated with virus suppression
    James M Reuben
    Department of Hematopathology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    J Allergy Clin Immunol 110:255-61. 2002
    ..Little is known about the cytokine production by peripheral blood cells of pediatric patients who have suppressed HIV-1 replication after highly active antiretroviral therapy (HAART)...
  20. ncbi Growth in HIV-infected children receiving antiretroviral therapy at a pediatric infectious diseases clinic in Uganda
    Mark M Kabue
    Baylor College of Medicine, Abbott Fund Children s Clinical Centre of Excellence, Malawi
    AIDS Patient Care STDS 22:245-51. 2008
    ..001). Weight-for-age percentile and z score improved significantly after initiation of ART. This pediatric population gained weight more rapidly than height after initiation of ART...
  21. ncbi Pharmacokinetics and pharmacodynamics of saquinavir in pediatric patients with human immunodeficiency virus infection
    Sibylle Grub
    F Hoffmann La Roche Ltd, Basel, Switzerland
    Clin Pharmacol Ther 71:122-30. 2002
    ....
  22. ncbi Selection of zidovudine resistance mutations and escape of human immunodeficiency virus type 1 from antiretroviral pressure in stavudine-treated pediatric patients
    Horst-Guenter Maxeiner
    Department of Virology, University Medical Center, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands
    J Infect Dis 185:1070-6. 2002
    ..The effect of these mutations on phenotypic stavudine susceptibility is relatively small but apparently large enough to be clinically significant...
  23. ncbi Perspectives on the pediatric HIV/AIDS pandemic: catalyzing access of children to care and treatment
    Mark W Kline
    The Baylor International Pediatric AIDS Initiative, Department of Pediatrics, Baylor College of Medicine, Texas Children s Hospital, Houston, Texas, USA
    Pediatrics 117:1388-93. 2006
    ....
  24. ncbi Pediatric and adult HIV/AIDS treatment: still worlds apart
    Mark W Kline
    Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA
    Res Initiat Treat Action 11:22-3. 2005
  25. ncbi A simplified weight-based method for pediatric drug dosing for zidovudine and didanosine in resource-limited settings
    Paul J Weidle
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Pediatr Infect Dis J 25:59-64. 2006
    ..Although weight and height can both be measured, it may be impractical to expect providers in resource-limited settings to estimate accurately body surface area...
  26. ncbi Editorial comment: challenges to pediatric adherence to antiretroviral medications
    Meg Gwynne Ferris
    AIDS Read 12:162-3. 2002
  27. ncbi High prevalence of hepatitis B virus markers in Romanian adolescents with human immunodeficiency virus infection
    Simona Maria Ruta
    Stefan S Nicolau Institute of Virology, Bucharest, Romania
    MedGenMed 7:68. 2005
    ..We evaluated the frequency of hepatitis coinfection in Romanian adolescents who were diagnosed with human immunodeficiency virus (HIV) infection prior to 1995...
  28. ncbi Treatment of human immunodeficiency virus (HIV) in children using antiretroviral drugs
    Gabriel Misango Anabwani
    Department of Paediatrics, Baylor College of Medicine and Texas Children s Hospital, Houston, USA
    Semin Pediatr Infect Dis 16:116-24. 2005
    ....
  29. ncbi Lipodystrophy syndrome in human immunodeficiency virus-infected children
    Rene A Amaya
    Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, USA
    Pediatr Infect Dis J 21:405-10. 2002
    ..003). CONCLUSIONS: Features associated with lipodystrophy syndrome arise in some HIV-infected children. Subjects receiving pediatric dosing regimens were less likely than those receiving adult regimens to develop lipodystrophy...
  30. ncbi Human immunodeficiency virus protease inhibitors
    Mark W Kline
    Baylor College of Medicine and Texas Children's Hospital, Houston, USA
    Pediatr Infect Dis J 22:1085-7. 2003
  31. ncbi Pharmacokinetics of saquinavir in children during long term treatment
    Sibylle Grub
    Pediatr Infect Dis J 21:712-3. 2002
  32. ncbi Education and preparation of physicians entering an international pediatric AIDS program: the Pediatric AIDS Corps
    Gordon E Schutze
    Department of Pediatrics, Baylor College of Medicine, Baylor International Pediatric AIDS Initiative, Houston, TX 77030, USA
    AIDS Patient Care STDS 22:709-14. 2008
    ..The foundation provided by this educational course was an important beginning for the PAC physicians. Other groups providing specialized care to patients in developing countries might consider a similar educational program...